,44 Cases that have either a PDGFRA or PDGFRB mutation associated with mast cell hyperplasia should be properly classified as “myeloid neoplasms with PDGFRA or PDGFRB rearrangements,” according to the World Health Organization’s classification system.3 Here, PDGFRB is linked to mastocytosis.